WO1999053075A2 - Proteines de regulation du cycle cellulaire cdc-16, dp-1, dp-2 et e2f tirees de plantes - Google Patents

Proteines de regulation du cycle cellulaire cdc-16, dp-1, dp-2 et e2f tirees de plantes Download PDF

Info

Publication number
WO1999053075A2
WO1999053075A2 PCT/US1999/007638 US9907638W WO9953075A2 WO 1999053075 A2 WO1999053075 A2 WO 1999053075A2 US 9907638 W US9907638 W US 9907638W WO 9953075 A2 WO9953075 A2 WO 9953075A2
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
acid fragment
seq
protein
isolated nucleic
Prior art date
Application number
PCT/US1999/007638
Other languages
English (en)
Other versions
WO1999053075A3 (fr
Inventor
Theodore M. Klein
Layo O. Morakinyo
Joan T. Odell
Hajime Sakai
Original Assignee
E.I. Du Pont De Nemours And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E.I. Du Pont De Nemours And Company filed Critical E.I. Du Pont De Nemours And Company
Priority to AU34783/99A priority Critical patent/AU3478399A/en
Priority to EP99916470A priority patent/EP1068334A2/fr
Publication of WO1999053075A2 publication Critical patent/WO1999053075A2/fr
Publication of WO1999053075A3 publication Critical patent/WO1999053075A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
    • Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants

Definitions

  • This invention is in the field of plant molecular biology. More specifically, this invention pertains to nucleic acid fragments encoding cell cycle regulatory proteins in plants and seeds.
  • Cells divide by duplicating their chromosomes and segregating one copy of each duplicated chromosome, as well as providing essential organelles, to each of two daughter cells. Regulation of cell division is critical for the normal development of multicellular organisms. A cell that is destined to grow and divide must pass through specific phases of a cell cycle: Gj, S (period of DNA synthesis), G2, and M (mitosis). Studies have shown that cell division is controlled via the regulation of two critical events during the cell cycle: initiation of DNA synthesis and the initiation of mitosis. Several kinase proteins control cell cycle progression through these events.
  • These protein kinases are heterodimeric proteins, having a cyclin-dependent kinase (Cdks) subunit and a cyclin subunit that provides the regulatory specificity to the heterodimeric protein.
  • Cdks cyclin-dependent kinase
  • These heterodimeric proteins regulate cell cycle by interacting with proteins involved in the initiation of DNA synthesis and mitosis and phosphorylating them at specific regulatory sites, activating some and inactivating others.
  • the cyclin subunit concentration varies in phase with cell cycle while the concentration of the Cdks remain relatively constant throughout the cell cycle.
  • transcription factor E2F genes encode a family of proteins that bind to the nucleotide sequence TTTCGCGC and regulate the expression of various cellular and viral promoters.
  • Another transcription factor family of proteins, DP-1 and DP-2 can form heterodimers with E2F proteins in vivo (Helin, K. et al. (1994) Genes Dev. 20: 1850-1861; Ivey-Hoyl M. et al. (1993) Mol. Cell Biol. 13(2):7S02-7S12; and Zhang, Y. et al. (1995) Oncogene 70(77J:2085-2093).
  • the E2F-DP transcription factors are major regulators of genes that are required for the progression of S-phase, such as DHFR and DNA polymerase alpha, and they play a critical role in cell cycle regulation and differentiation.
  • the retinoblastoma tumor suppressor protein has been shown to induce growth arrest by binding to E2F-DP and repressing its activity.
  • CDC-16 is cell cycle protein identified in mammalian and yeast cells. This protein has been shown to localize to the centrosome and mitotic spindle and is essential for the metaphase to anaphase transition during cell division (Lamb, J. R. et al. (1994) EMBO J. 75(iS):4321-4328).
  • cell cycle regulatory proteins There is a great deal of interest in identifying the genes that encode cell cycle regulatory proteins in plants. These genes may be used to express cell cycle regulatory nucleic acid sequences encoding all or a portion of a cell cycle regulatory protein would facilitate studies to better understand cell cycle regulation in plants, provide genetic tools to enhance cell growth in tissue culture, increase the efficiency of gene transfer and help provide more stable transformations. Cell cycle regulatory proteins may also provide targets to facilitate design and/or identification of inhibitors of cell cycle regulatory proteins that may be useful as herbicides.
  • the instant invention relates to isolated nucleic acid fragments encoding cell cycle regulatory proteins. Specifically, this invention concerns an isolated nucleic acid fragment encoding a CDC-16, DP-1, DP-2 or E2F protein. In addition, this invention relates to a nucleic acid fragment that is complementary to the nucleic acid fragment encoding a CDC-16, DP-1, DP-2 or E2F protein.
  • An additional embodiment of the instant invention pertains to a polypeptide encoding all or a substantial portion of a cell cycle regulatory protein selected from the group consisting of CDC-16, DP-1, DP-2 and E2F.
  • the instant invention relates to a chimeric gene encoding a CDC-16, DP-1, DP-2 or E2F protein, or to a chimeric gene that comprises a nucleic acid fragment that is complementary to a nucleic acid fragment encoding a CDC-16, DP-1, DP-2 or E2F protein, operably linked to suitable regulatory sequences, wherein expression of the chimeric gene results in production of levels of the encoded protein in a transformed host cell that is altered (i.e., increased or decreased) from the level produced in an untransformed host cell.
  • the instant invention concerns a transformed host cell comprising in its genome a chimeric gene encoding a CDC-16, DP-1, DP-2 or E2F protein, operably linked to suitable regulatory sequences. Expression of the chimeric gene results in production of altered levels of the encoded protein in the transformed host cell.
  • the transformed host cell can be of eukaryotic or prokaryotic origin, and include cells derived from higher plants and microorganisms.
  • the invention also includes transformed plants that arise from transformed host cells of higher plants, and seeds derived from such transformed plants.
  • An additional embodiment of the instant invention concerns a method of altering the level of expression of a CDC-16, DP-1, DP-2 or E2F protein in a transformed host cell comprising: a) transforming a host cell with a chimeric gene comprising a nucleic acid fragment encoding a CDC-16, DP-1, DP-2 or E2F protein; and b) growing the transformed host cell under conditions that are suitable for expression of the chimeric gene wherein expression of the chimeric gene results in production of altered levels of CDC-16, DP-1, DP-2 or E2F protein in the transformed host cell.
  • An addition embodiment of the instant invention concerns a method for obtaining a nucleic acid fragment encoding all or a substantial portion of an amino acid sequence encoding a CDC-16, DP-1, DP-2 or E2F protein.
  • a further embodiment of the instant invention is a method for evaluating at least one compound for its ability to inhibit the activity of a CDC-16, DP-1, DP-2 or E2F protein, the method comprising the steps of: (a) transforming a host cell with a chimeric gene comprising a nucleic acid fragment encoding a CDC-16, DP-1, DP-2 or E2F protein, operably linked to suitable regulatory sequences; (b) growing the transformed host cell under conditions that are suitable for expression of the chimeric gene wherein expression of the chimeric gene results in production of CDC-16, DP-1, DP-2 or E2F protein in the transformed host cell; (c) optionally purifying the CDC-16, DP-1, DP-2 or E2F protein expressed by the transformed host cell; (d) treating the CDC-16, DP-1, DP-2 or E2F protein with a compound to be tested; and (e) comparing the activity of the CDC-16, DP-1, DP-2 or E2F protein that has been
  • SEQ ID NO:l is the nucleotide sequence comprising a portion of the cDNA insert in clone cpflc.pk001.kl3 encoding a portion of a corn CDC-16 protein.
  • SEQ ID NO:2 is the deduced amino acid sequence of a portion of a CDC- 16 protein derived from the nucleotide sequence of SEQ ID NO: 1.
  • SEQ ID NO:3 is the nucleotide sequence comprising a portion of the cDNA insert in clone sfll.pk0030.e3 encoding a portion of a soybean CDC-16 protein.
  • SEQ ID NO:4 is the deduced amino acid sequence of a portion of a CDC-16 protein derived from the nucleotide sequence of SEQ ID NO:3.
  • SEQ ID NO:5 is the nucleotide sequence comprising a portion of the cDNA insert in clone ids.pk0025.f7 encoding a portion of an Impatiens balsamia DP-1 protein.
  • SEQ ID NO:6 is the deduced amino acid sequence of a portion of a DP-1 protein derived from the nucleotide sequence of SEQ ID NO:5.
  • SEQ ID NO:7 is the nucleotide sequence comprising a portion of the cDNA insert in clone p0072.comfs64r encoding a portion of a corn DP-1 protein.
  • SEQ ID NO:8 is the deduced amino acid sequence of a portion of a DP-1 protein derived from the nucleotide sequence of SEQ ID NO:7.
  • SEQ ID NO:9 is the nucleotide sequence comprising a portion of the cDNA insert in clone src3c.pk018.ml 1 encoding a portion of a soybean DP-1 protein.
  • SEQ ID NO: 10 is the deduced amino acid sequence of a portion of a DP-1 protein derived from the nucleotide sequence of SEQ ID NO:9.
  • SEQ ID NO: 11 is the nucleotide sequence comprising a contig assembled from the cDNA inserts in clones p0005.cbmfh22r, cdelc.pk001.jl3 and cen3n.pk0183.b9 encoding a portion of a corn DP-2 protein.
  • SEQ ID NO: 12 is the deduced amino acid sequence of a portion of a DP-2 protein derived from the nucleotide sequence of SEQ ID NO:l 1.
  • SEQ ID NO: 13 is the nucleotide sequence comprising the entire cDNA insert in clone wlmkl .pk0005.e2 encoding a portion of a wheat DP-2 protein.
  • SEQ ID NO: 14 is the deduced amino acid sequence of a portion of a DP-2 protein derived from the nucleotide sequence of SEQ ID NO: 13.
  • SEQ ID NO: 15 is the nucleotide sequence comprising a portion of the cDNA insert in clone rsl 1 n.pk004.d 15 encoding a portion of a rice E2F protein.
  • SEQ ID NO: 16 is the deduced amino acid sequence of a portion of an E2F protein derived from the nucleotide sequence of SEQ ID NO: 15.
  • SEQ ID NO: 17 is the nucleotide sequence comprising the entire cDNA insert in clone sel.pk0012.f4 encoding a portion of a soybean E2F protein.
  • SEQ ID NO: 18 is the deduced amino acid sequence of a portion of an E2F protein derived from the nucleotide sequence of SEQ ID NO: 17.
  • the Sequence Listing contains the one letter code for nucleotide sequence characters and the three letter codes for amino acids as defined in conformity with the IUPAC-IUBMB standards described in Nucleic Acids Research 75:3021-3030 (1985) and in the Biochemical Journal 219 (No. ):345-373 (1984) which are herein incorporated by reference.
  • the symbols and format used for nucleotide and amino acid sequence data comply with the rules set forth in 37 C.F.R. ⁇ 1.822.
  • an "isolated nucleic acid fragment” is a polymer of RNA or DNA that is single- or double- stranded, optionally containing synthetic, non-natural or altered nucleotide bases.
  • An isolated nucleic acid fragment in the form of a polymer of DNA may be comprised of one or more segments of cDNA, genomic DNA or synthetic DNA.
  • "contig” refers to an assemblage of overlapping nucleic acid sequences to form one contiguous nucleotide sequence. For example, several DNA sequences can be compared and aligned to identify common or overlapping regions.
  • nucleic acid fragments wherein changes in one or more nucleotide bases results in substitution of one or more amino acids, but do not affect the functional properties of the protein encoded by the DNA sequence.
  • substantially similar also refers to nucleic acid fragments wherein changes in one or more nucleotide bases does not affect the ability of the nucleic acid fragment to mediate alteration of gene expression by antisense or co-suppression technology.
  • substantially similar also refers to modifications of the nucleic acid fragments of the instant invention such as deletion or insertion of one or more nucleotides that do not substantially affect the functional properties of the resulting transcript vis-a-vis the ability to mediate alteration of gene expression by antisense or co-suppression technology or alteration of the functional properties of the resulting protein molecule. It is therefore understood that the invention encompasses more than the specific exemplary sequences.
  • antisense suppression and co-suppression of gene expression may be accomplished using nucleic acid fragments representing less than the entire coding region of a gene, and by nucleic acid fragments that do not share 100% sequence identity with the gene to be suppressed.
  • alterations in a gene which result in the production of a chemically equivalent amino acid at a given site, but do not effect the functional properties of the encoded protein are well known in the art.
  • a codon for the amino acid alanine, a hydrophobic amino acid may be substituted by a codon encoding another less hydrophobic residue, such as glycine, or a more hydrophobic residue, such as valine, leucine, or isoleucine.
  • a codon encoding another less hydrophobic residue such as glycine
  • a more hydrophobic residue such as valine, leucine, or isoleucine.
  • changes which result in substitution of one negatively charged residue for another such as aspartic acid for glutamic acid, or one positively charged residue for another, such as lysine for arginine, can also be expected to produce a functionally equivalent product.
  • Nucleotide changes which result in alteration of the N-terminal and C-terminal portions of the protein molecule would also not be expected to alter the activity of the protein.
  • substantially similar nucleic acid fragments may also be characterized by their ability to hybridize, under stringent conditions (0.1X SSC, 0.1% SDS, 65°C), with the nucleic acid fragments disclosed herein.
  • Substantially similar nucleic acid fragments of the instant invention may also be characterized by the percent similarity of the amino acid sequences that they encode to the amino acid sequences disclosed herein, as determined by algorithms commonly employed by those skilled in this art. Preferred are those nucleic acid fragments whose nucleotide sequences encode amino acid sequences that are 80% similar to the amino acid sequences reported herein. More preferred nucleic acid fragments encode amino acid sequences that are 90% similar to the amino acid sequences reported herein. Most preferred are nucleic acid fragments that encode amino acid sequences that are 95% similar to the amino acid sequences reported herein.
  • PENALTY 10) (hereafter Clustal algorithm).
  • a "substantial portion" of an amino acid or nucleotide sequence comprises enough of the amino acid sequence of a polypeptide or the nucleotide sequence of a gene to afford putative identification of that polypeptide or gene, either by manual evaluation of the sequence by one skilled in the art, or by computer-automated sequence comparison and identification using algorithms such as BLAST (Basic Local Alignment Search Tool; Altschul, S. F., et al., (1993) J. Mol Biol. 275:403-410; see also www.ncbi.nlm.nih.gov/BLAST/).
  • BLAST Basic Local Alignment Search Tool
  • a sequence often or more contiguous amino acids or thirty or more nucleotides is necessary in order to putatively identify a polypeptide or nucleic acid sequence as homologous to a known protein or gene.
  • gene specific oligonucleotide probes comprising 20-30 contiguous nucleotides may be used in sequence-dependent methods of gene identification (e.g., Southern hybridization) and isolation (e.g., in situ hybridization of bacterial colonies or bacteriophage plaques).
  • short oligonucleotides of 12-15 bases may be used as amplification primers in PCR in order to obtain a particular nucleic acid fragment comprising the primers.
  • a "substantial portion" of a nucleotide sequence comprises enough of the sequence to afford specific identification and/or isolation of a nucleic acid fragment comprising the sequence.
  • the instant specification teaches partial or complete amino acid and nucleotide sequences encoding one or more particular plant proteins.
  • the skilled artisan, having the benefit of the sequences as reported herein, may now use all or a substantial portion of the disclosed sequences for purposes known to those skilled in this art. Accordingly, the instant invention comprises the complete sequences as reported in the accompanying Sequence Listing, as well as substantial portions of those sequences as defined above.
  • Codon degeneracy refers to divergence in the genetic code permitting variation of the nucleotide sequence without effecting the amino acid sequence of an encoded polypeptide. Accordingly, the instant invention relates to any nucleic acid fragment that encodes all or a substantial portion of the amino acid sequence encoding the CDC-16, DP-1 , DP-2 or E2F proteins as set forth in SEQ ID NOs:2, 4, 6, 8, 10, 12, 14, 16 and 18.
  • the skilled artisan is well aware of the "codon-bias" exhibited by a specific host cell in usage of nucleotide codons to specify a given amino acid. Therefore, when synthesizing a gene for improved expression in a host cell, it is desirable to design the gene such that its frequency of codon usage approaches the frequency of preferred codon usage of the host cell.
  • “Synthetic genes” can be assembled from oligonucleotide building blocks that are chemically synthesized using procedures known to those skilled in the art. These building blocks are ligated and annealed to form gene segments which are then enzymatically assembled to construct the entire gene. "Chemically synthesized”, as related to a sequence of DNA, means that the component nucleotides were assembled in vitro. Manual chemical synthesis of DNA may be accomplished using well established procedures, or automated chemical synthesis can be performed using one of a number of commercially available machines. Accordingly, the genes can be tailored for optimal gene expression based on optimization of nucleotide sequence to reflect the codon bias of the host cell.
  • Gene refers to a nucleic acid fragment that expresses a specific protein, including regulatory sequences preceding (5' non-coding sequences) and following (3' non-coding sequences) the coding sequence.
  • Native gene refers to a gene as found in nature with its own regulatory sequences.
  • Chimeric gene refers any gene that is not a native gene, comprising regulatory and coding sequences that are not found together in nature.
  • a chimeric gene may comprise regulatory sequences and coding sequences that are derived from different sources, or regulatory sequences and coding sequences derived from the same source, but arranged in a manner different than that found in nature.
  • Endogenous gene refers to a native gene in its natural location in the genome of an organism.
  • a “foreign” gene refers to a gene not normally found in the host organism, but that is introduced into the host organism by gene transfer.
  • Foreign genes can comprise native genes inserted into a non-native organism, or chimeric genes.
  • a “transgene” is a gene that has been introduced into the genome by a transformation procedure.
  • Coding sequence refers to a DNA sequence that codes for a specific amino acid sequence.
  • Regulatory sequences refer to nucleotide sequences located upstream (5' non- coding sequences), within, or downstream (3' non-coding sequences) of a coding sequence, and which influence the transcription, RNA processing or stability, or translation of the associated coding sequence. Regulatory sequences may include promoters, translation leader sequences, introns, and polyadenylation recognition sequences.
  • Promoter refers to a DNA sequence capable of controlling the expression of a coding sequence or functional RNA.
  • a coding sequence is located 3' to a promoter sequence.
  • the promoter sequence consists of proximal and more distal upstream elements, the latter elements often referred to as enhancers.
  • an “enhancer” is a DNA sequence which can stimulate promoter activity and may be an innate element of the promoter or a heterologous element inserted to enhance the level or tissue-specificity of a promoter. Promoters may be derived in their entirety from a native gene, or be composed of different elements derived from different promoters found in nature, or even comprise synthetic DNA segments.
  • promoters may direct the expression of a gene in different tissues or cell types, or at different stages of development, or in response to different environmental conditions. Promoters which cause a gene to be expressed in most cell types at most times are commonly referred to as "constitutive promoters". New promoters of various types useful in plant cells are constantly being discovered; numerous examples may be found in the compilation by Okamuro and Goldberg, (1989) Biochemistry of Plants 75:1-82. It is further recognized that since in most cases the exact boundaries of regulatory sequences have not been completely defined, DNA fragments of different lengths may have identical promoter activity.
  • translation leader sequence refers to a DNA sequence located between the promoter sequence of a gene and the coding sequence.
  • the translation leader sequence is present in the fully processed mRNA upstream of the translation start sequence.
  • the translation leader sequence may affect processing of the primary transcript to mRNA, mRNA stability or translation efficiency. Examples of translation leader sequences have been described (Turner, R. and Foster, G. D. (1995) Molecular Biotechnology 3:225).
  • the "3" non-coding sequences refer to DNA sequences located downstream of a coding sequence and include polyadenylation recognition sequences and other sequences encoding regulatory signals capable of affecting mRNA processing or gene expression.
  • the polyadenylation signal is usually characterized by affecting the addition of polyadenylic acid tracts to the 3' end of the mRNA precursor.
  • the use of different 3' non-coding sequences is exemplified by Ingelbrecht et al., (1989) Plant Cell 7:671-680.
  • RNA transcript refers to the product resulting from RNA polymerase-catalyzed transcription of a DNA sequence. When the RNA transcript is a perfect complementary copy of the DNA sequence, it is referred to as the primary transcript or it may be a RNA sequence derived from posttranscriptional processing of the primary transcript and is referred to as the mature RNA.
  • Messenger RNA (mRNA) refers to the RNA that is without introns and that can be translated into protein by the cell.
  • cDNA refers to a double-stranded DNA that is complementary to and derived from mRNA.
  • Sense RNA transcript that includes the mRNA and so can be translated into protein by the cell.
  • Antisense RNA refers to a RNA transcript that is complementary to all or part of a target primary transcript or mRNA and that blocks the expression of a target gene (U.S. Pat. No. 5,107,065, incorporated herein by reference). The complementarity of an antisense RNA may be with any part of the specific gene transcript, i.e., at the 5' non-coding sequence, 3' non-coding sequence, introns, or the coding sequence.
  • “Functional RNA” refers to sense RNA, antisense RNA, ribozyme RNA, or other RNA that may not be translated but yet has an effect on cellular processes.
  • operably linked refers to the association of nucleic acid sequences on a single nucleic acid fragment so that the function of one is affected by the other.
  • a promoter is operably linked with a coding sequence when it is capable of affecting the expression of that coding sequence (i.e., that the coding sequence is under the transcriptional control of the promoter).
  • Coding sequences can be operably linked to regulatory sequences in sense or antisense orientation.
  • expression refers to the transcription and stable accumulation of sense (mRNA) or antisense RNA derived from the nucleic acid fragment of the invention. Expression may also refer to translation of mRNA into a polypeptide.
  • Antisense inhibition refers to the production of antisense RNA transcripts capable of suppressing the expression of the target protein.
  • Overexpression refers to the production of a gene product in transgenic organisms that exceeds levels of production in normal or non-transformed organisms.
  • Co-suppression refers to the production of sense RNA transcripts capable of suppressing the expression of identical or substantially similar foreign or endogenous genes (U.S. Patent No. 5,231,020, incorporated herein by reference).
  • altered levels refers to the production of gene product(s) in transgenic organisms in amounts or proportions that differ from that of normal or non-transformed organisms.
  • “Mature” protein refers to a post-translationally processed polypeptide; i.e., one from which any pre- or propeptides present in the primary translation product have been removed.
  • Precursor protein refers to the primary product of translation of mRNA; i.e., with pre- and propeptides still present. Pre- and propeptides may be but are not limited to intracellular localization signals.
  • chloroplast transit peptide is an amino acid sequence which is translated in conjunction with a protein and directs the protein to the chloroplast or other plastid types present in the cell in which the protein is made.
  • Chloroplast transit sequence refers to a nucleotide sequence that encodes a chloroplast transit peptide.
  • a “signal peptide” is an amino acid sequence which is translated in conjunction with a protein and directs the protein to the secretory system (Chrispeels, J. J., (1991) Ann. Rev. Plant Phys. Plant Mol. Biol 42:21-53).
  • a vacuolar targeting signal can further be added, or if to the endoplasmic reticulum, an endoplasmic reticulum retention signal (supra) may be added.
  • an endoplasmic reticulum retention signal may be added.
  • any signal peptide present should be removed and instead a nuclear localization signal included (Raikhel (1992) Plant Phys. 700:1627-1632).
  • Transformation refers to the transfer of a nucleic acid fragment into the genome of a host organism, resulting in genetically stable inheritance. Host organisms containing the transformed nucleic acid fragments are referred to as "transgenic" organisms. Examples of methods of plant transformation include Agrobacterium-mediated transformation (De Blaere et al. (1987) Meth. Enzymol. 143:277) and particle-accelerated or “gene gun” transformation technology (Klein et al. (1987) Nature (London) 327:70-73; U.S. Patent No. 4,945,050, incorporated herein by reference).
  • Nucleic acid fragments encoding at least a portion of several cell cycle regulatory proteins have been isolated and identified by comparison of random plant cDNA sequences to public databases containing nucleotide and protein sequences using the BLAST algorithms well known to those skilled in the art. Table 1 lists the proteins that are described herein, and the designation of the cDNA clones that comprise the nucleic acid fragments encoding these proteins.
  • the nucleic acid fragments of the instant invention may be used to isolate cDNAs and genes encoding homologous proteins from the same or other plant species. Isolation of homologous genes using sequence-dependent protocols is well known in the art. Examples of sequence-dependent protocols include, but are not limited to, methods of nucleic acid hybridization, and methods of DNA and RNA amplification as exemplified by various uses of nucleic acid amplification technologies (e.g., polymerase chain reaction, ligase chain reaction).
  • genes encoding other CDC-16, DP-1, DP-2 or E2F proteins, either as cDNAs or genomic DNAs could be isolated directly by using all or a portion of the instant nucleic acid fragments as DNA hybridization probes to screen libraries from any desired plant employing methodology well known to those skilled in the art.
  • Specific oligonucleotide probes based upon the instant nucleic acid sequences can be designed and synthesized by methods known in the art (Maniatis). Moreover, the entire sequences can be used directly to synthesize DNA probes by methods known to the skilled artisan such as random primer DNA labeling, nick translation, or end-labeling techniques, or RNA probes using available in vitro transcription systems.
  • primers can be designed and used to amplify a part or all of the instant sequences.
  • the resulting amplification products can be labeled directly during amplification reactions or labeled after amplification reactions, and used as probes to isolate full length cDNA or genomic fragments under conditions of appropriate stringency.
  • two short segments of the instant nucleic acid fragments may be used in polymerase chain reaction protocols to amplify longer nucleic acid fragments encoding homologous genes from DNA or RNA.
  • the polymerase chain reaction may also be performed on a library of cloned nucleic acid fragments wherein the sequence of one primer is derived from the instant nucleic acid fragments, and the sequence of the other primer takes advantage of the presence of the polyadenylic acid tracts to the 3' end of the mRNA precursor encoding plant genes.
  • the second primer sequence may be based upon sequences derived from the cloning vector.
  • the skilled artisan can follow the RACE protocol (Frohman et al., (1988) PNAS USA ⁇ 5:8998) to generate cDNAs by using PCR to amplify copies of the region between a single point in the transcript and the 3' or 5' end.
  • Primers oriented in the 3' and 5' directions can be designed from the instant sequences.
  • 3' RACE or 5' RACE systems BBL
  • specific 3' or 5' cDNA fragments can be isolated (Ohara et al., (1989) PNAS USA 86:5673; Loh et al., (1989) Science 243:2]7).
  • Products generated by the 3' and 5' RACE procedures can be combined to generate full-length cDNAs (Frohman, M. A. and Martin, G. R., (1989) Techniques 7:165).
  • Synthetic peptides representing portions of the instant amino acid sequences may be synthesized. These peptides can be used to immunize animals to produce polyclonal or monoclonal antibodies with specificity for peptides or proteins comprising the amino acid sequences. These antibodies can be then be used to screen cDNA expression libraries to isolate full-length cDNA clones of interest (Lerner, R. A. (1984) Adv. Immunol 36:1; Maniatis).
  • nucleic acid fragments of the instant invention may be used to create transgenic plants in which the disclosed CDC-16, DP-1, DP-2 or E2F proteins are present at higher or lower levels than normal or in cell types or developmental stages in which they are not normally found. This would have the effect of altering cell cycle regulation those cells.
  • Overexpression of the CDC-16, DP-1, DP-2 or E2F proteins of the instant invention may be accomplished by first constructing a chimeric gene in which the coding region is operably linked to a promoter capable of directing expression of a gene in the desired tissues at the desired stage of development.
  • the chimeric gene may comprise promoter sequences and translation leader sequences derived from the same genes. 3' Non-coding sequences encoding transcription termination signals may also be provided.
  • the instant chimeric gene may also comprise one or more introns in order to facilitate gene expression.
  • Plasmid vectors comprising the instant chimeric gene can then constructed.
  • the choice of plasmid vector is dependent upon the method that will be used to transform host plants. The skilled artisan is well aware of the genetic elements that must be present on the plasmid vector in order to successfully transform, select and propagate host cells containing the chimeric gene. The skilled artisan will also recognize that different independent transformation events will result in different levels and patterns of expression (Jones et al., (1985) EMBOJ. 4:24] 1-2418; De Almeida et al, (1989) Mol Gen. Genetics 275:78-86), and thus that multiple events must be screened in order to obtain lines displaying the desired expression level and pattern. Such screening may be accomplished by Southern analysis of DNA, Northern analysis of mRNA expression, Western analysis of protein expression, or phenotypic analysis.
  • a chimeric gene designed for co-suppression of the instant cell cycle regulatory proteins can be constructed by linking a gene or gene fragment encoding a CDC-16, DP-1 , DP-2 or E2F protein to plant promoter sequences.
  • a chimeric gene designed to express antisense RNA for all or part of the instant nucleic acid fragment can be constructed by linking the gene or gene fragment in reverse orientation to plant promoter sequences. Either the co-suppression or antisense chimeric genes could be introduced into plants via transformation wherein expression of the corresponding endogenous genes are reduced or eliminated.
  • the instant CDC-16, DP-1, DP-2 or E2F proteins may be produced in heterologous host cells, particularly in the cells of microbial hosts, and can be used to prepare antibodies to the these proteins by methods well known to those skilled in the art.
  • the antibodies are useful for detecting CDC-16, DP-1, DP-2 or E2F proteins in situ in cells or in vitro in cell extracts.
  • Preferred heterologous host cells for production of the instant CDC-16, DP-1, DP-2 or E2F proteins are microbial hosts. Microbial expression systems and expression vectors containing regulatory sequences that direct high level expression of foreign proteins are well known to those skilled in the art.
  • any of these could be used to construct a chimeric gene for production of the instant CDC-16, DP-1, DP-2 or E2F proteins.
  • This chimeric gene could then be introduced into appropriate microorganisms via transformation to provide high level expression of the encoded cell cycle regulatory protein.
  • An example of a vector for high level expression of the instant CDC-16, DP-1, DP-2 or E2F proteins in a bacterial host is provided (Example 9).
  • the instant CDC-16, DP-1, DP-2 or E2F proteins can be used as a targets to facilitate design and/or identification of inhibitors of those proteins that may be useful as herbicides.
  • CDC-16, DP-1, DP-2 or E2F proteins described herein are involved in the regulation of cell cycle. Accordingly, inhibition of the activity of one or more of the proteins described herein could lead to inhibition plant growth.
  • the instant CDC-16, DP-1, DP-2 or E2F proteins could be appropriate for new herbicide discovery and design.
  • nucleic acid fragments of the instant invention may also be used as probes for genetically and physically mapping the genes that they are a part of, and as markers for traits linked to those genes. Such information may be useful in plant breeding in order to develop lines with desired phenotypes.
  • the instant nucleic acid fragments may be used as restriction fragment length polymorphism (RFLP) markers.
  • RFLP restriction fragment length polymorphism
  • Southern blots (Maniatis) of restriction-digested plant genomic DNA may be probed with the nucleic acid fragments of the instant invention. The resulting banding patterns may then be subjected to genetic analyses using computer programs such as MapMaker (Lander et al., (1987) Genomics 7:174-181) in order to construct a genetic map.
  • nucleic acid fragments of the instant invention may be used to probe Southern blots containing restriction endonuclease-treated genomic DNAs of a set of individuals representing parent and progeny of a defined genetic cross. Segregation of the DNA polymorphisms is noted and used to calculate the position of the instant nucleic acid sequence in the genetic map previously obtained using this population (Botstein, D. et al., (1980) Am. J. Hum. Genet. 52:314-331).
  • nucleic acid probes derived from the instant nucleic acid sequences may be used in direct fluorescence in situ hybridization (FISH) mapping (Trask, B. J. (1991) Trends Genet. 7:149-154).
  • FISH direct fluorescence in situ hybridization
  • a variety of nucleic acid amplification-based methods of genetic and physical mapping may be carried out using the instant nucleic acid sequences. Examples include allele-specific amplification (Kazazian, H. H. (1989) J. Lab. Clin. Med.
  • the sequence of a nucleic acid fragment is used to design and produce primer pairs for use in the amplification reaction or in primer extension reactions.
  • the design of such primers is well known to those skilled in the art.
  • short segments of the instant nucleic acid fragments may be used in polymerase chain reaction protocols in conjunction with a mutation tag sequence primer on DNAs prepared from a population of plants in which Mutator transposons or some other mutation-causing DNA element has been introduced (see Bensen, supra). The amplification of a specific DNA fragment with these primers indicates the insertion of the mutation tag element in or near the plant gene encoding the CDC-16, DP-1, DP-2 or E2F protein.
  • the instant nucleic acid fragment may be used as a hybridization probe against PCR amplification products generated from the mutation population using the mutation tag sequence primer in conjunction with an arbitrary genomic site primer, such as that for a restriction enzyme site-anchored synthetic adaptor.
  • an arbitrary genomic site primer such as that for a restriction enzyme site-anchored synthetic adaptor.
  • EXAMPLE 1 Composition of cDNA Libraries; Isolation and Sequencing of cDNA Clones cDNA libraries representing mRNAs from various corn, Impatiens, rice, soybean and wheat tissues were prepared. The characteristics of the libraries are described below.
  • cDNA libraries were prepared in Uni-ZAPTM XR vectors according to the manufacturer's protocol (Stratagene Cloning Systems, La Jolla, CA). Conversion of the Uni-ZAPTM XR libraries into plasmid libraries was accomplished according to the protocol provided by Stratagene. Upon conversion, cDNA inserts were contained in the plasmid vector pBluescript. cDNA inserts from randomly picked bacterial colonies containing recombinant pBluescript plasmids were amplified via polymerase chain reaction using primers specific for vector sequences flanking the inserted cDNA sequences or plasmid DNA was prepared from cultured bacterial cells.
  • Amplified insert DNAs or plasmid DNAs were sequenced in dye-primer sequencing reactions to generate partial cDNA sequences (expressed sequence tags or "ESTs"; see Adams, M. D. et al., (1991) Science 252:1651). The resulting ESTs were analyzed using a Perkin Elmer Model 377 fluorescent sequencer.
  • SEQ ID NO: 1 The sequence of a portion of the cDNA insert from clone cpflc.pk001.kl3 is shown in SEQ ID NO: 1; the deduced amino acid sequence of this cDNA, which represents 14% of the N-terminal region of the protein, is shown in SEQ ID NO:2.
  • SEQ ID NO:2 A calculation of the percent similarity of the amino acid sequence set forth in SEQ ID NO:2 and the Homo sapiens sequence (using the Clustal algorithm) revealed that the protein encoded by SEQ ID NO:2 is 40% similar to the Homo sapiens CDC-16 protein.
  • SEQ ID NO:3 The sequence of a portion of the cDNA insert from clone sfll.pk0030.e3 is shown in SEQ ID NO:3; the deduced amino acid sequence of this cDNA, which represents 43% of the protein (middle region), is shown in SEQ ID NO:4.
  • a calculation of the percent similarity of the amino acid sequence set forth in SEQ ID NO:4 and the Homo sapiens sequence (using the Clustal algorithm) revealed that the protein encoded by SEQ ID NO:4 is 46% similar to the Homo sapiens CDC-16 protein.
  • the percent similarity between the corn and soybean amino acid sequence was calculated to be 18% using the Clustal algorithm.
  • BLAST scores and probabilities indicate that the instant nucleic acid fragments encode portions of CDC-16 proteins. These sequences represent the first plant sequences encoding CDC-16 proteins.
  • the BLASTX search using the EST sequences from clones p0072.comfs64r and src3c.pk018.ml 1 revealed similarity of the proteins encoded by the cDNAs to DP-1 protein from Mus musculus (NCBI Identifier No. gi 420232).
  • the BLAST results for each of these ESTs are shown in Table 4:
  • SEQ ID NO:5 The sequence of a portion of the cDNA insert from clone ids.pk0025.f7 is shown in SEQ ID NO:5; the deduced amino acid sequence of this cDNA, which represents 33% of the of the protein (middle region), is shown in SEQ ID NO:6.
  • SEQ ID NO: 8 A calculation of the percent similarity of the amino acid sequence set forth in SEQ ID NO: 8 and the Xenopus laevis sequence (using the Clustal algorithm) revealed that the protein encoded by SEQ ID NO:6 is 46%) similar to the Xenopus laevis DP-1 protein.
  • SEQ ID NO:7 The sequence of a portion of the cDNA insert from clone p0072.comfs64r is shown in SEQ ID NO:7; the deduced amino acid sequence of this cDNA, which represents 23% of the protein (middle region), is shown in SEQ ID NO:8.
  • SEQ ID NO:8 A calculation of the percent similarity of the amino acid sequence set forth in SEQ ID NO:8 and the Mus musculus sequence (using the Clustal algorithm) revealed that the protein encoded by SEQ ID NO: 8 is 37% similar to the Mus musculus DP-1 protein.
  • SEQ ID NO:9 The sequence of a portion of the cDNA insert from clone src3c.pk018.ml 1 is shown in SEQ ID NO:9; the deduced amino acid sequence of this cDNA, which represents 42% of the protein (middle region), is shown in SEQ ID NO: 10.
  • a calculation of the percent similarity of the amino acid sequence set forth in SEQ ID NO: 10 and the Mus musculus sequence revealed that the protein encoded by SEQ ID NO: 10 is 48% similar to the Mus musculus DP-1 protein.
  • the percent similarity between the corn, Impatiens and soybean amino acid sequence was calculated to range between 31 to 78% using the Clustal algorithm.
  • SEQ ID NO:l l The sequence of the corn contig composed of clones p0005.cbmfh22r, cdelc.pk001.jl3 and cen3n.pk0183.b9 is shown in SEQ ID NO:l l; the deduced amino acid sequence of this contig, which represents 50% of the protein (middle region), is shown in SEQ ID NO:12.
  • SEQ ID NO: 12 A calculation of the percent similarity of the amino acid sequence set forth in SEQ ID NO: 12 and the Homo sapiens sequence (using the Clustal algorithm) revealed that the protein encoded by SEQ ID NO:8 is 52% similar to the Homo sapiens DP-2 protein.
  • SEQ ID NO:8 The sequence of the entire cDNA insert from clone wlmkl. pk0005.e2 is shown in SEQ
  • SEQ ID NO: 13 the deduced amino acid sequence of this cDNA, which represents 25% of the of the protein (middle region), is shown in SEQ ID NO: 14.
  • a calculation of the percent similarity of the amino acid sequence set forth in SEQ ID NO: 14 and the Mus species sequence revealed that the protein encoded by SEQ ID NO: 14 is 44% similar to the Mus species DP-2 protein.
  • the percent similarity between the corn and wheat amino acid sequence was calculated to be 86% using the Clustal algorithm.
  • BLAST scores and probabilities indicate that the instant nucleic acid fragments encode portions of DP-2 proteins. These sequences represent the first plant sequences encoding DP-2 proteins.
  • EXAMPLE 6 Characterization of cDNA Clones Encoding E2F Proteins
  • the BLASTX search using the EST sequence from clone rslln.pk004.dl5 revealed similarity of the protein encoded by the cDNA to E2F-4 protein from Homo sapiens (NCBI Identifier No. gi 1061146).
  • the BLASTX search using the EST sequence from clone sel.pk0012.f4 revealed similarity of the protein encoded by the cDNA to E2F protein from Drosophila melanogaster (NCBI Identifier No. gi 3551069).
  • SEQ ID NO: 15 The sequence of a portion of the cDNA insert from clone rslln.pk004.dl5 is shown in SEQ ID NO: 15; the deduced amino acid sequence of this cDNA, which represents 12% of the of the protein (middle region), is shown in SEQ ID NO: 16.
  • a calculation of the percent similarity of the amino acid sequence set forth in SEQ ID NO: 16 and the Homo sapiens sequence revealed that the protein encoded by SEQ ID NO: 16 is 49% similar to the Homo sapiens E2F-4 protein.
  • the sequence of the entire cDNA insert from clone sel.pk0012.f4 is shown in SEQ ID NO:
  • SEQ ID NO: 17 the deduced amino acid sequence of this cDNA, which represents 10% of the of the protein (middle region), is shown in SEQ ID NO: 18.
  • a calculation of the percent similarity of the amino acid sequence set forth in SEQ ID NO: 18 and the Drosophila melanogaster sequence revealed that the protein encoded by SEQ ID NO: 18 is 43% similar to the Drosophila melanogaster E2F protein.
  • the percent similarity between the rice and soybean amino acid sequence was calculated to be 15% using the Clustal algorithm.
  • a chimeric gene comprising a cDNA encoding a cell cycle regulatory protein in sense orientation with respect to the maize 27 kD zein promoter that is located 5' to the cDNA fragment, and the 10 kD zein 3' end that is located 3' to the cDNA fragment, can be constructed.
  • the cDNA fragment of this gene may be generated by polymerase chain reaction (PCR) of the cDNA clone using appropriate oligonucleotide primers. Cloning sites (Ncol or Smal) can be incorporated into the oligonucleotides to provide proper orientation of the DNA fragment when inserted into the digested vector pML103 as described below.
  • Plasmid pML103 has been deposited under the terms of the Budapest Treaty at ATCC (American Type Culture Collection, 10801 University Boulevard., Manassas, VA 20110-2209), and bears accession number ATCC 97366.
  • the DNA segment from pML103 contains a 1.05 kb Sall-Ncol promoter fragment of the maize 27 kD zein gene and a 0.96 kb Smal-Sall fragment from the 3' end of the maize 10 kD zein gene in the vector pGem9Zf(+) (Promega).
  • Vector and insert DNA can be ligated at 15°C overnight, essentially as described (Maniatis). The ligated DNA may then be used to transform E. coli XL 1 -Blue (Epicurian Coli XL-1 BlueTM; Stratagene).
  • Bacterial transformants can be screened by restriction enzyme digestion of plasmid DNA and limited nucleotide sequence analysis using the dideoxy chain termination method (SequenaseTM DNA Sequencing Kit; U.S. Biochemical).
  • the resulting plasmid construct would comprise a chimeric gene encoding, in the 5' to 3' direction, the maize 27 kD zein promoter, a cDNA fragment encoding a cell cycle regulatory protein, and the 10 kD zein 3' region.
  • the chimeric gene described above can then be introduced into corn cells by the following procedure. Immature corn embryos can be dissected from developing caryopses derived from crosses of the inbred corn lines H99 and LH132.
  • the embryos are isolated 10 to 11 days after pollination when they are 1.0 to 1.5 mm long.
  • the embryos are then placed with the axis-side facing down and in contact with agarose-solidified N6 medium (Chu et al., (1975) Sci. Sin. Peking 18:659-668).
  • the embryos are kept in the dark at 27°C.
  • Friable embryogenic callus consisting of undifferentiated masses of cells with somatic proembryoids and embryoids borne on suspensor structures proliferates from the scutellum of these immature embryos.
  • the embryogenic callus isolated from the primary explant can be cultured on N6 medium and sub-cultured on this medium every 2 to 3 weeks.
  • the plasmid, p35S/Ac (obtained from Dr. Peter Eckes, Hoechst Ag, Frankfurt, Germany) may be used in transformation experiments in order to provide for a selectable marker.
  • This plasmid contains the Pat gene (see European Patent Publication 0242236) which encodes phosphinothricin acetyl transferase (PAT).
  • PAT phosphinothricin acetyl transferase
  • the enzyme PAT confers resistance to herbicidal glutamine synthetase inhibitors such as phosphinothricin.
  • the pat gene in p35S/Ac is under the control of the 35S promoter from Cauliflower Mosaic Virus (Odell et al. (1985) Nature 313:810-812) and the 3' region of the nopaline synthase gene from the T-DNA of the Ti plasmid of Agrobacterium tumefaciens.
  • the particle bombardment method (Klein et al, (1987) Nature 327:70-73) may be used to transfer genes to the callus culture cells.
  • gold particles (1 ⁇ m in diameter) are coated with DNA using the following technique.
  • Ten ⁇ g of plasmid DNAs are added to 50 ⁇ L of a suspension of gold particles (60 mg per mL).
  • Calcium chloride 50 ⁇ L of a 2.5 M solution
  • spermidine free base (20 ⁇ L of a 1.0 M solution) are added to the particles.
  • the suspension is vortexed during the addition of these solutions. After 10 minutes, the tubes are briefly centrifuged (5 sec at 15,000 rpm) and the supernatant removed.
  • the particles are resuspended in 200 ⁇ L of absolute ethanol, centrifuged again and the supernatant removed. The ethanol rinse is performed again and the particles resuspended in a final volume of 30 ⁇ L of ethanol.
  • An aliquot (5 ⁇ L) of the DNA-coated gold particles can be placed in the center of a KaptonTM flying disc (Bio-Rad Labs).
  • the particles are then accelerated into the corn tissue with a BiolisticTM PDS-1000/He (Bio-Rad Instruments, Hercules CA), using a helium pressure of 1000 psi, a gap distance of 0.5 cm and a flying distance of 1.0 cm.
  • the embryogenic tissue is placed on filter paper over agarose- solidified N6 medium.
  • the tissue is arranged as a thin lawn and covered a circular area of about 5 cm in diameter.
  • the petri dish containing the tissue can be placed in the chamber of the PDS-1000/ ⁇ e approximately 8 cm from the stopping screen.
  • the air in the chamber is then evacuated to a vacuum of 28 inches of Hg.
  • the macrocarrier is accelerated with a helium shock wave using a rupture membrane that bursts when the He pressure in the shock tube reaches 1000 psi.
  • Seven days after bombardment the tissue can be transferred to N6 medium that contains gluphosinate (2 mg per liter) and lacks casein or proline. The tissue continues to grow slowly on this medium.
  • tissue can be transferred to fresh N6 medium containing gluphosinate. After 6 weeks, areas of about 1 cm in diameter of actively growing callus can be identified on some of the plates containing the glufosinate- supplemented medium. These calli may continue to grow when sub-cultured on the selective medium.
  • Plants can be regenerated from the transgenic callus by first transferring clusters of tissue to N6 medium supplemented with 0.2 mg per liter of 2,4-D. After two weeks the tissue can be transferred to regeneration medium (Fromm et al., (1990) Bio/Technology 5:833-839).
  • a seed-specific expression cassette composed of the promoter and transcription terminator from the gene encoding the ⁇ subunit of the seed storage protein phaseolin from the bean Phaseolus vulgaris (Doyle et al. (1986) J. Biol. Chem. 26] :9228-9238) can be used for expression of the instant cell cycle regulatory protein in transformed soybean.
  • the phaseolin cassette includes about 500 nucleotides upstream (5') from the translation initiation codon and about 1650 nucleotides downstream (3') from the translation stop codon of phaseolin.
  • Nco I which includes the ATG translation initiation codon
  • Sma I which includes the ATG translation initiation codon
  • Kpn I The entire cassette is flanked by Hind III sites.
  • the cDNA fragment of this gene may be generated by polymerase chain reaction (PCR) of the cDNA clone using appropriate oligonucleotide primers. Cloning sites can be incorporated into the oligonucleotides to provide proper orientation of the DNA fragment when inserted into the expression vector. Amplification is then performed as described above, and the isolated fragment is inserted into a pUC18 vector carrying the seed expression cassette.
  • PCR polymerase chain reaction
  • Soybean embroys may then be transformed with the expression vector comprising a sequence encoding a cell cycle regulatory protein.
  • somatic embryos cotyledons, 3-5 mm in length dissected from surface sterilized, immature seeds of the soybean cultivar A2872, can be cultured in the light or dark at 26°C on an appropriate agar medium for 6-10 weeks. Somatic embryos which produce secondary embryos are then excised and placed into a suitable liquid medium. After repeated selection for clusters of somatic embryos which multiplied as early, globular staged embryos, the suspensions are maintained as described below.
  • Soybean embryogenic suspension cultures can maintained in 35 mL liquid media on a rotary shaker, 150 rpm, at 26°C with florescent lights on a 16:8 hour day/night schedule. Cultures are subcultured every two weeks by inoculating approximately 35 mg of tissue into 35 mL of liquid medium.
  • Soybean embryogenic suspension cultures may then be transformed by the method of particle gun bombardment (Kline et al. (1987) Nature (London) 527:70, U.S. Patent No. 4,945,050).
  • a DuPont BiolisticTM PDS1000/HE instrument helium retrofit
  • a selectable marker gene which can be used to facilitate soybean transformation is a chimeric gene composed of the 35S promoter from Cauliflower Mosaic Virus (Odell et al. (1985) Nature 575:810-812), the hygromycin phosphotransferase gene from plasmid pJR225 (from E. coli; Gritz et al.
  • the seed expression cassette comprising the phaseolin 5' region, the fragment encoding the cell cycle regulatory protein and the phaseolin 3' region can be isolated as a restriction fragment. This fragment can then be inserted into a unique restriction site of the vector carrying the marker gene.
  • the particle preparation is then agitated for three minutes, spun in a microfuge for 10 seconds and the supernatant removed.
  • the DNA-coated particles are then washed once in 400 ⁇ L 70% ethanol and resuspended in 40 ⁇ L of anhydrous ethanol.
  • the DNA particle suspension can be sonicated three times for one second each. Five ⁇ L of the DNA-coated gold particles are then loaded on each macro carrier disk.
  • Approximately 300-400 mg of a two-week-old suspension culture is placed in an empty 60x15 mm petri dish and the residual liquid removed from the tissue with a pipette.
  • approximately 5-10 plates of tissue are normally bombarded.
  • Membrane rupture pressure is set at 1100 psi and the chamber is evacuated to a vacuum of 28 inches mercury.
  • the tissue is placed approximately 3.5 inches away from the retaining screen and bombarded three times. Following bombardment, the tissue can be divided in half and placed back into liquid and cultured as described above.
  • the liquid media may be exchanged with fresh media, and eleven to twelve days post bombardment with fresh media containing 50 mg/mL hygromycin. This selective media can be refreshed weekly.
  • green, transformed tissue may be observed growing from untransformed, necrotic embryogenic clusters. Isolated green tissue is removed and inoculated into individual flasks to generate new, clonally propagated, transformed embryogenic suspension cultures. Each new line may be treated as an independent transformation event. These suspensions can then be subcultured and maintained as clusters of immature embryos or regenerated into whole plants by maturation and germination of individual somatic embryos.
  • EXAMPLE 9 Expression of Chimeric Genes in Microbial Cells
  • the cDNAs encoding the instant cell cycle regulatory proteins can be inserted into the T7 E. coli expression vector pBT430.
  • This vector is a derivative of pET-3a (Rosenberg et al. (1987) Gene 5(5:125-135) which employs the bacteriophage T7 RNA polymerase/T7 promoter system.
  • Plasmid pBT430 was constructed by first destroying the EcoR I and Hind III sites in pET-3a at their original positions. An oligonucleotide adaptor containing EcoR I and Hind III sites was inserted at the BamH I site of pET-3a.
  • the fragment can then be purified from the agarose gel by digestion with GELaseTM (Epicentre Technologies) according to the manufacturer's instructions, ethanol precipitated, dried and resuspended in 20 ⁇ L of water.
  • Appropriate oligonucleotide adapters may be ligated to the fragment using T4 DNA ligase (New England Biolabs, Beverly, MA).
  • T4 DNA ligase New England Biolabs, Beverly, MA
  • the fragment containing the ligated adapters can be purified from the excess adapters using low melting agarose as described above.
  • the vector pBT430 is digested, dephosphorylated with alkaline phosphatase (NEB) and deproteinized with phenol/chloroform as decribed above.
  • the prepared vector pBT430 and fragment can then be ligated at 16°C for 15 hours followed by transformation into DH5 electrocompetent cells (GIBCO BRL).
  • Transformants can be selected on agar plates containing LB media and 100 ⁇ g/mL ampicillin. Transformants containing the gene encoding the cell cycle regulatory protein are then screened for the correct orientation with respect to the T7 promoter by restriction enzyme analysis.
  • a plasmid clone with the cDNA insert in the correct orientation relative to the T7 promoter can be transformed into E. coli strain BL21(DE3) (Studier et al. (1986) J. Mol. Biol. 189:] 13-130). Cultures are grown in LB medium containing ampicillin (100 mg/L) at 25°C. At an optical density at 600 nm of approximately 1, IPTG (isopropylthio- ⁇ -galactoside, the inducer) can be added to a final concentration of 0.4 mM and incubation can be continued for 3 h at 25°.
  • IPTG isopropylthio- ⁇ -galactoside, the inducer
  • Cells are then harvested by centrifugation and re-suspended in 50 ⁇ L of 50 mM Tris-HCl at pH 8.0 containing 0.1 mM DTT and 0.2 mM phenyl methylsulfonyl fluoride.
  • a small amount of 1 mm glass beads can be added and the mixture sonicated 3 times for about 5 seconds each time with a microprobe sonicator.
  • the mixture is centrifuged and the protein concentration of the supernatant determined.
  • One ⁇ g of protein from the soluble fraction of the culture can be separated by SDS-polyacrylamide gel electrophoresis. Gels can be observed for protein bands migrating at the expected molecular weight.
  • EXAMPLE 10 Evaluating Compounds for Their ability to Inhibit the Activity of Cell Cycle Regulatory Proteins
  • the cell cycle regulatory proteins described herein may be produced using any number of methods known to those skilled in the art. Such methods include, but are not limited to, expression in bacteria as described in Example 9, or expression in eukaryotic cell culture, inplanta, and using viral expression systems in suitably infected organisms or cell lines.
  • the instant cell cycle regulatory proteins may be expressed either as mature forms of the proteins as observed in vivo or as fusion proteins by covalent attachment to a variety of enzymes, proteins or affinity tags. Common fusion protein partners include glutathione S-transferase (“GST”), thioredoxin (“Trx”), maltose binding protein, and C- and/or
  • GST glutathione S-transferase
  • Trx thioredoxin
  • maltose binding protein and C- and/or
  • the fusion proteins may be engineered with a protease recognition site at the fusion point so that fusion partners can be separated by protease digestion to yield intact mature enzyme.
  • proteases include thrombin, enterokinase and factor Xa.
  • any protease can be used which specifically cleaves the peptide connecting the fusion protein and the enzyme.
  • Purification of the instant cell cycle regulatory proteins may utilize any number of separation technologies familiar to those skilled in the art of protein purification. Examples of such methods include, but are not limited to, homogenization, filtration, centrifugation, heat denaturation, ammonium sulfate precipitation, desalting, pH precipitation, ion exchange chromatography, hydrophobic interaction chromatography and affinity chromatography, wherein the affinity ligand represents a substrate, substrate analog or inhibitor.
  • the purification protocol may include the use of an affinity resin which is specific for the fusion protein tag attached to the expressed enzyme or an affinity resin containing ligands which are specific for the enzyme.
  • a cell cycle regulatory protein may be expressed as a fusion protein coupled to the C-terminus of thioredoxin.
  • a (His) peptide may be engineered into the N-terminus of the fused thioredoxin moiety to afford additional opportunities for affinity purification.
  • Other suitable affinity resins could be synthesized by linking the appropriate ligands to any suitable resin such as Sepharose-4B.
  • a thioredoxin fusion protein may be eluted using dithiothreitol; however, elution may be accomplished using other reagents which interact to displace the thioredoxin from the resin. These reagents include ⁇ -mercaptoethanol or other reduced thiol.
  • the eluted fusion protein may be subjected to further purification by traditional means as stated above, if desired.
  • Proteolytic cleavage of the thioredoxin fusion protein and the enzyme may be accomplished after the fusion protein is purified or while the protein is still bound to the ThioBondTM affinity resin or other resin.
  • Crude, partially purified or purified protein, either alone or as a fusion protein, may be utilized in assays for the evaluation of compounds for their ability to inhibit enzymatic activition of the cell cycle regulatory proteins disclosed herein. Assays may be conducted under well known experimental conditions which permit optimal protein activity. For example, assays for E2F and DP-1 transcription factor activities are presented by Helin K., et al., 1994 Genes Dev. 70:1850-1861 and Ivey-Hoyl M., et al., 1993 Mol. Cell Biol. 75f2j:7802-7812. Assays for DP-2 activity are presented by Zhang Y., et al., 1995 Oncogene 10(11):20 >5-2093. Assays for CDC-16 activity are presented by Lamb, J. R., et al., ]994 EMBOJ. 75(7 ⁇ °j:4321--4328.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

Cette invention se rapporte à un fragment d'acide nucléique isolé codant une protéine de régulation du cycle cellulaire, ainsi qu'à la construction d'un gène chimérique codant la totalité ou une partie de cette protéine de régulation du cycle cellulaire, selon une orientation sens ou anti-sens, l'expression de ce gène chimérique entraînant la production de niveaux modifiés de cette protéine de régulation du cycle cellulaire dans une cellule hôte transformée.
PCT/US1999/007638 1998-04-09 1999-04-08 Proteines de regulation du cycle cellulaire cdc-16, dp-1, dp-2 et e2f tirees de plantes WO1999053075A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU34783/99A AU3478399A (en) 1998-04-09 1999-04-08 Cell cycle regulatory proteins cdc-16, dp-1, dp-2 and e2f from plants
EP99916470A EP1068334A2 (fr) 1998-04-09 1999-04-08 Proteines de regulation du cycle cellulaire cdc-16, dp-1, dp-2 et e2f tirees de plantes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8113298P 1998-04-09 1998-04-09
US60/081,132 1998-04-09

Publications (2)

Publication Number Publication Date
WO1999053075A2 true WO1999053075A2 (fr) 1999-10-21
WO1999053075A3 WO1999053075A3 (fr) 2000-03-23

Family

ID=22162293

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US1999/007638 WO1999053075A2 (fr) 1998-04-09 1999-04-08 Proteines de regulation du cycle cellulaire cdc-16, dp-1, dp-2 et e2f tirees de plantes
PCT/US1999/007640 WO1999053069A2 (fr) 1998-04-09 1999-04-08 Proteines de regulation du cycle cellulaire

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/US1999/007640 WO1999053069A2 (fr) 1998-04-09 1999-04-08 Proteines de regulation du cycle cellulaire

Country Status (4)

Country Link
EP (2) EP1068335A2 (fr)
AR (2) AR015756A1 (fr)
AU (2) AU3478399A (fr)
WO (2) WO1999053075A2 (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047614A1 (fr) * 1999-02-12 2000-08-17 Pioneer Hi-Bred International, Inc. Plantes transgeniques a expression modifiee de la proteine dp
WO2001021644A2 (fr) * 1999-09-24 2001-03-29 Consejo Superior De Investigaciones Cientificas Proteines du reactif associe de dimerisation (dp) du ble et utilisations correspondantes
WO2005117568A1 (fr) 2004-05-28 2005-12-15 Cropdesign N.V. Plantes ayant des caracteristiques de croissance ameliorees et leur procede d'obtention
US8329144B2 (en) 1999-10-01 2012-12-11 Isis Innovation Limited Diagnostic and therapeutic epitope, and transgenic plant
US9017690B2 (en) 2004-04-28 2015-04-28 Btg International Limited Epitopes related to coeliac disease
US10053497B2 (en) 2002-06-05 2018-08-21 Oxford University Innovation Limited Therapeutic epitopes and uses thereof
US10105437B2 (en) 2004-04-28 2018-10-23 Btg International Limited Epitopes related to coeliac disease

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU780301B2 (en) * 1999-09-27 2005-03-17 Pioneer Hi-Bred International, Inc. Enhanced stress tolerance in maize via manipulation of cell cycle regulatory genes

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994010307A1 (fr) * 1992-10-29 1994-05-11 Medical Research Council Facteur de transcription dp-1
WO1996001425A2 (fr) * 1994-07-01 1996-01-18 Medical Research Council Dosage de recherche d'inhibiteurs de la proteine dp-1 et d'autres proteines dp
WO1997043647A1 (fr) * 1996-05-15 1997-11-20 Medical Research Council Signaux de localisation nucleaire des proteines dp et e2f et leur utilisation
WO1997047745A1 (fr) * 1996-06-13 1997-12-18 Consejo Superior De Investigaciones Cientificas Proteines vegetales associees au retinoblastome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294538A (en) * 1991-11-18 1994-03-15 Cold Spring Harbor Labs. Method of screening for antimitotic compounds using the CDC25 tyrosine phosphatase
US5821234A (en) * 1992-09-10 1998-10-13 The Board Of Trustees Of The Leland Stanford Junior University Inhibition of proliferation of vascular smooth muscle cell
US5674748A (en) * 1995-03-14 1997-10-07 Thomas Jefferson University Human cyclin-dependent kinase-like proteins and methods of using the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994010307A1 (fr) * 1992-10-29 1994-05-11 Medical Research Council Facteur de transcription dp-1
WO1996001425A2 (fr) * 1994-07-01 1996-01-18 Medical Research Council Dosage de recherche d'inhibiteurs de la proteine dp-1 et d'autres proteines dp
WO1997043647A1 (fr) * 1996-05-15 1997-11-20 Medical Research Council Signaux de localisation nucleaire des proteines dp et e2f et leur utilisation
WO1997047745A1 (fr) * 1996-06-13 1997-12-18 Consejo Superior De Investigaciones Cientificas Proteines vegetales associees au retinoblastome

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
COLASANTI J ET AL.: "Isolation and characterization of cDNA clones encoding a functional p34cdc2 homologue from Zea mays" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE USA, vol. 88, April 1991 (1991-04), pages 3377-3381, XP002113194 *
DATABASE EMHTG [Online] EMBL Heidelberg, Germany AC/ID AB019226, 16 November 1998 (1998-11-16) NAKAMURA Y: "Structural analysis of Arabidopsis thaliana chromosome 5" XP002127847 *
DATABASE EMHTG [Online] EMBL, Heidelberg, Germany AC/ID AB007651, 31 October 1997 (1997-10-31) NAKAMURA Y ET AL.: "Structural analysis of Arabidopsis thaliana chromosome 5" XP002127845 *
DATABASE R57U036 [Online] EMBL, Heidelberg, Germany AC/ID AB010693, 3 February 1998 (1998-02-03) NAKAMURA Y: "Structural analysis of Arabidopsis thaliana chromosome 5" XP002127846 *
DATABASE R58U022 [Online] EMBL, Heidelberg, Germany AC AI487429, 17 March 1999 (1999-03-17) ALCALA J ET AL.: "Generation of ESTs from tomato carpel tissue" XP002127848 *
DUDITS ET AL: "Cyclin-dependent and calcium-dependent kinase families: response of cell division cycle to hormone and stress signals" PORTLAND PRESS RESEARCH MONOGRAPH,1996, pages 21-45, XP002080506 ISSN: 0964-5845 *
HASHIMOTO J ET AL.: "Isolation and characterization of cDNA clones encoding cdc2 homologues from Oryza sativa: a functional homologue and cognate variants" MOLECULAR AND GENERAL GENETICS, vol. 233, no. 1-2, May 1992 (1992-05), pages 10-16, XP002113196 *
LAMB J R ET AL: "CDC16P, CDC23P AND CDC27P FORM A COMPLEX ESSENTIAL FOR MITOSIS" EMBO JOURNAL, vol. 13, no. 18, 15 September 1994 (1994-09-15), pages 4321-4328, XP002030313 ISSN: 0261-4189 cited in the application *
MIAO G-H ET AL.: "Two functional soybean genes encoding p34cdc2 protein kinases are regulated by different plant developmental pathways" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE USA, vol. 90, February 1993 (1993-02), pages 943-947, XP002113195 *
VEYLDER DE L ET AL: "THE ARABIDOPSIS CKS1 AT PROTEIN BINDS THE CYCLIN-DEPENDENT KINASES CDC2AAT AND CDC2BAT" FEBS LETTERS, vol. 412, no. 3, 4 August 1997 (1997-08-04), pages 446-452, XP002047992 ISSN: 0014-5793 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047614A1 (fr) * 1999-02-12 2000-08-17 Pioneer Hi-Bred International, Inc. Plantes transgeniques a expression modifiee de la proteine dp
WO2001021644A2 (fr) * 1999-09-24 2001-03-29 Consejo Superior De Investigaciones Cientificas Proteines du reactif associe de dimerisation (dp) du ble et utilisations correspondantes
WO2001021644A3 (fr) * 1999-09-24 2001-10-04 Consejo Superior Investigacion Proteines du reactif associe de dimerisation (dp) du ble et utilisations correspondantes
US8329144B2 (en) 1999-10-01 2012-12-11 Isis Innovation Limited Diagnostic and therapeutic epitope, and transgenic plant
US10053497B2 (en) 2002-06-05 2018-08-21 Oxford University Innovation Limited Therapeutic epitopes and uses thereof
US9017690B2 (en) 2004-04-28 2015-04-28 Btg International Limited Epitopes related to coeliac disease
US10105437B2 (en) 2004-04-28 2018-10-23 Btg International Limited Epitopes related to coeliac disease
WO2005117568A1 (fr) 2004-05-28 2005-12-15 Cropdesign N.V. Plantes ayant des caracteristiques de croissance ameliorees et leur procede d'obtention

Also Published As

Publication number Publication date
AU3478599A (en) 1999-11-01
EP1068334A2 (fr) 2001-01-17
EP1068335A2 (fr) 2001-01-17
WO1999053069A3 (fr) 2000-03-23
AU3478399A (en) 1999-11-01
AR015757A1 (es) 2001-05-16
WO1999053075A3 (fr) 2000-03-23
AR015756A1 (es) 2001-05-16
WO1999053069A2 (fr) 1999-10-21

Similar Documents

Publication Publication Date Title
US20100138956A1 (en) Nitrogen transport metabolism
WO1999049058A2 (fr) Enzyme de biosynthese du tryptophane
US20060008820A1 (en) Cell cycle genes in plants
EP1068334A2 (fr) Proteines de regulation du cycle cellulaire cdc-16, dp-1, dp-2 et e2f tirees de plantes
EP1062355A1 (fr) Inhibiteurs de proteines d'apoptose dans les plantes
US20060288441A1 (en) Plant genes encoding pantothenate synthetase
WO2000005386A2 (fr) Enzymes impliquees dans la biosynthese du chorismate
EP1044264A2 (fr) Enzymes biosynthetiques a acides amines ramifies
US6653099B1 (en) Plant UDP-glucose dehydrogenase
US20050148765A1 (en) Plant cell cyclin genes
US6849783B2 (en) Plant biotin synthase
US6573426B1 (en) Gene involved in pyrimidine biosynthesis in plants
US6911331B2 (en) Chorismate biosynthesis enzymes
US7659450B2 (en) Lcb1 subunit of serine palmitoyltransferase
US6653531B1 (en) Chorismate synthase from plants
EP1002089A1 (fr) Genes de codage de dr1 et drap1, complexes represseurs globaux de la transcription
US20050059047A1 (en) Plant SUGI homologs
EP1338652A2 (fr) Génés de cycline de cellules végétales
EP1200568A2 (fr) Gene du metabolisme de la purine dans les vegetaux
WO1999004004A1 (fr) Homologue vegetal de l'ada2 de la levure, un adaptateur de transcription
US20030104409A1 (en) Vitamin B metabolism proteins
WO1999049053A1 (fr) Sous-unite lcb1 de serine palmitoyltransferase
EP1478224A2 (fr) Peptide deformylase
WO1999049021A1 (fr) Sous-unite lcb2 de serine palmitoyltransferase
WO1999002689A1 (fr) Homologues des proteines sug 1 vegetales

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AU BA BB BG BR CA CN CU CZ EE GD GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO SG SI SK SL TR TT UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AU BA BB BG BR CA CN CU CZ EE GD GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO SG SI SK SL TR TT UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 1999916470

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09673481

Country of ref document: US

NENP Non-entry into the national phase in:

Ref country code: KR

WWP Wipo information: published in national office

Ref document number: 1999916470

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999916470

Country of ref document: EP